Itacitinib Completed Phase 2 Trials for Psoriasis Vulgaris (Plaque Psoriasis) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01634087A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis